Department of Gastroenterology, Children's Hospital of Fudan University, 399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
Center for Molecular Medicine, Pediatrics Research Institute, Children's Hospital of Fudan University, Shanghai, 201102, China.
BMC Gastroenterol. 2021 Apr 13;21(1):167. doi: 10.1186/s12876-021-01756-y.
Defects in interleukin 10 (IL10) and its receptors are particularly involved in very early onset inflammatory bowel disease (VEOIBD). However, large fragment deletions of IL10 receptor A (IL10RA) are rare.
VEOIBD patients with confirmed mutations in the IL10RA gene were enrolled from January 1, 2019 to June 30, 2020. The clinical features and endoscopic-radiological findings of the patients with large fragment deletions of the IL10RA gene were determined and followed up.
Thirty-five patients with IL10RA gene mutations, namely, 28 compound heterozygous mutations and 7 homozygote mutations, were enrolled in this study. Six patients carried the reported point mutation c.301C > T (p. R101RW) or c.537 G > A (p. T179T) in one locus and a large fragment deletion in exon 1 in another locus, which were novel mutations in this gene. A 333-bp deletion of exon 1 (117857034-11857366 del) was the main mutation in this locus in 85.7% of the patients with large fragment deletions. The time of disease onset ranged from birth to 4 years, and diarrhea was the main initial symptom. In total, 6/7 patients had perianal complications, including perianal abscess, fistula and skin tags. Six patients accepted thalidomide treatment, 5/7 accepted mesalamine, 3/7 accepted hematopoietic stem cell transplantation (HSCT), and 3/7 were waiting for HSCT.
We identified a novel large deletion of exon 1 involving the IL10RA gene for the first time and showed the characteristics of VEOIBD patients. This study expands the spectrum of Chinese VEOIBD patients with IL0RA gene mutations.
白细胞介素 10(IL10)及其受体的缺陷尤其与极早发性炎症性肠病(VEOIBD)有关。然而,IL10 受体 A(IL10RA)的大片段缺失较为罕见。
2019 年 1 月 1 日至 2020 年 6 月 30 日期间,我们招募了经 IL10RA 基因突变证实的 VEOIBD 患者。我们确定并随访了这些患者的 IL10RA 基因大片段缺失的临床特征和内镜-影像学表现。
本研究共纳入 35 例 IL10RA 基因突变患者,包括 28 例复合杂合突变和 7 例纯合突变。6 例患者在一个基因座携带报道的点突变 c.301C>T(p.R101RW)或 c.537G>A(p.T179T),而在另一个基因座携带大片段缺失,这是该基因的新突变。85.7%的大片段缺失患者该基因座的主要突变是外显子 1 的 333-bp 缺失(117857034-11857366del)。疾病发病时间从出生到 4 岁不等,腹泻是主要的首发症状。共有 6/7 例患者存在肛周并发症,包括肛周脓肿、瘘管和皮赘。6 例患者接受了沙利度胺治疗,5/7 例接受了美沙拉嗪,3/7 例接受了造血干细胞移植(HSCT),3/7 例正在等待 HSCT。
我们首次发现了涉及 IL10RA 基因的新型外显子 1 大片段缺失,并显示了 VEOIBD 患者的特征。本研究扩展了中国 IL0RA 基因突变的 VEOIBD 患者谱。